Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

New Test Identifies Positive Tuberculosis Cases Within the Hour

By LabMedica International staff writers
Posted on 27 Sep 2010
A new test can identify positive tuberculosis (TB) cases within one hour, ensuring quick treatment for patients and reducing the incidence and consequences of TB worldwide.

Researchers at the Health Protection Agency (HPA; London, United Kingdom) developed a new ultra rapid test for the TB bacteria, Mycobacterium tuberculosis, which substantially increases the sensitivity of the test, enabling detection of the presence of the bacteria in a sample within an hour. More...
The new technique is a single DNA molecule identification test, which uses real-time polymerase chain reaction (PCR).

The new test focuses on a particular DNA region within the TB bacterium, which the researchers say is present in all strains of the disease. According to the researchers, the test can pick up very small amount of bacteria, and appears to be as sensitive as the gold standard TB identification, a bacterial culture grown from mucus coughed up from the lungs. However, the standard test can take up to eight weeks to reach a diagnosis, by which time the individual might have infected many more people. The study findings were presented at the HPA's annual conference, held during September 2010 at the University of Warwick (United Kingdom).

"We're excited to have developed this new test because it means we can potentially diagnose someone at a TB clinic within an hour and start them immediately on the treatment they need,” said study author Catherine Arnold, Ph.D., head of the HPA's genomic services unit. "This new test could really have an impact where it is most needed.”

TB is a common and often deadly infectious disease that usually attacks the lungs, but can also affect other parts of the body. Most infections in humans result in an asymptomatic, latent infection, but about one in ten latent infections eventually progresses to active disease which, if left untreated, kills more than 50% of its victims. The World Health Organization (WHO, Geneva, Switzerland) has estimated that one third of the world's population carries TB bacteria, and recent years have seen resurgence in TB infections in developed countries, as well as the rise of strains resistant to medication.

Related Links:

Health Protection Agency
University of Warwick
World Health Organization


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.